Cargando…
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient
Chordoma is a rare, but aggressive bone tumor with a high recurrence rate that primarily arises at the cranial and caudal ends of the axial skeleton. Systemic chemotherapies are not effective against the tumor, and outside of surgical resection and radiation, no approved options are available. Progn...
Autores principales: | Kesari, Santosh, Williams, Jeannie, Burbano, Erica, Stirn, Meaghan, Caroen, Scott, Oronsky, Bryan, Reid, Tony, Larson, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051040/ https://www.ncbi.nlm.nih.gov/pubmed/37008834 http://dx.doi.org/10.1159/000529503 |
Ejemplares similares
-
Data Management 101 for drug developers: A peek behind the curtain
por: Oronsky, Bryan, et al.
Publicado: (2023) -
Patent and Marketing Exclusivities 101 for Drug Developers
por: Oronsky, Bryan, et al.
Publicado: (2023) -
Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME)
por: Reid, Tony, et al.
Publicado: (2023) -
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001
por: Hammond, Terese Catherine, et al.
Publicado: (2022) -
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in Rats
por: Caroen, Scott, et al.
Publicado: (2022)